Article ID Journal Published Year Pages File Type
2506978 International Journal of Pharmaceutics 2006 6 Pages PDF
Abstract

The objective was to use normal flora to deliver protein/peptide drugs orally. A probiotic bacterium, Lactococcus lactis subsp. lactis (L. lactis) transformed with Plasmid ss80, which made it able to synthesize and secrete β-lactamase, a 29 kDa protein, was used as the delivery system for β-lactamase. Oral absorption of β-lactamase in rats when delivered by this L. lactis system was investigated. The oral bioavailability of β-lactamase delivered by 3 × 107 of the L. lactis was equivalent to 209 mU of i.v. dose, and the estimated relative bioavailability was 16.7%. When delivered by β-lactamase free solution form, the relative oral bioavailability was 4.7%, which increased to 6.0% when co-administered with 3 × 107 of the untransformed L. lactis. The results demonstrated that the L. lactis significantly increased the β-lactamase oral bioavailability by 2–3-folds (p < 0.01), the mean residence time (MRT) by 3–4 times (p < 0.01), and the mean absorption time (MAT) by 6–14 times (p < 0.01), as compared to the free solution form with/without the untransformed L. lactis. In conclusion, the L. lactis is more efficient in delivering β-lactamase orally compared with the free solution form. It also provides a sustained delivery mechanism for β-lactamase. Gene-transformed normal flora may be used as an efficient and sustained delivery system for protein drugs through oral route.

Related Topics
Health Sciences Pharmacology, Toxicology and Pharmaceutical Science Pharmaceutical Science
Authors
, ,